Torrent Pharma

64
Hold
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
3,787.20
-14.45 (-0.38%)
BSENSE

Dec 05

BSE+NSE Vol: 77.86 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
11,516.00
10,727.00
9,620.00
8,508.00
8,004.00
7,939.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
11,516.00
10,727.00
9,620.00
8,508.00
8,004.00
7,939.00
Expenditure (Ex Depriciation)
Stock Adjustments
-274.00
-155.00
166.00
73.00
-279.00
-133.00
Raw Materials Consumed
3,050.00
2,841.00
2,569.00
2,368.00
2,425.00
2,300.00
Power & Fuel Cost
137.00
145.00
155.00
144.00
122.00
128.00
Employee Cost
2,203.00
1,984.00
1,677.00
1,526.00
1,439.00
1,429.00
Operating Expenses
215.00
197.00
176.00
183.00
163.00
136.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1,260.00
1,129.00
1,026.00
884.00
742.00
807.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
681.00
672.00
530.00
501.00
510.00
591.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
7,795.00
7,360.00
6,778.00
6,076.00
5,519.00
5,768.00
Operating Profit (PBDIT) excl Other Income
3,720.00
3,367.00
2,842.00
2,431.00
2,485.00
2,170.00
Other Income
23.00
57.00
45.00
196.00
56.00
121.00
Operating Profit (PBDIT)
3,744.00
3,425.00
2,887.00
2,627.00
2,542.00
2,291.00
Interest
252.00
353.00
333.00
255.00
358.00
450.00
Profit before Depriciation and Tax
3,491.00
3,072.00
2,553.00
2,372.00
2,184.00
1,840.00
Depreciation
794.00
808.00
706.00
662.00
657.00
654.00
Profit Before Taxation & Exceptional Items
2,697.00
2,263.00
1,847.00
1,710.00
1,526.00
1,186.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
2,672.00
2,352.00
1,847.00
1,225.00
1,526.00
1,186.00
Provision for Tax
761.00
695.00
601.00
448.00
274.00
161.00
Profit After Tax
1,911.00
1,656.00
1,245.00
777.00
1,251.00
1,024.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
3,942.00
3,303.00
2,916.00
2,806.00
1,893.00
1,616.00
Profit Available for appropriations
5,853.00
4,959.00
4,161.00
3,583.00
3,144.00
2,641.00
Appropriations
5,853.00
4,959.00
4,161.00
3,583.00
3,144.00
2,641.00
Equity Dividend (%)
640.00%
560.00%
440.00%
960.00%
700.00%
640.00%
Earnings Per Share
56.47
48.94
36.79
22.96
73.98
60.55
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 7.35% vs 11.51% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 10.49% vs 18.49% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -28.64% vs 6.03% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 15.39% vs 33.02% in Mar 2024

Compare Profit and Loss Results of Torrent Pharma
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
11,516.00
9,360.00
2,156.00
23.03%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
11,516.00
9,360.00
2,156.00
23.03%
Expenditure (Ex Depriciation)
Stock Adjustments
-274.00
-96.00
-178.00
-185.42%
Raw Materials Consumed
3,050.00
3,821.00
-771.00
-20.18%
Power & Fuel Cost
137.00
465.00
-328.00
-70.54%
Employee Cost
2,203.00
1,243.00
960.00
77.23%
Operating Expenses
215.00
387.00
-172.00
-44.44%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1,260.00
136.00
1,124.00
826.47%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
681.00
157.00
524.00
333.76%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
7,795.00
6,391.00
1,404.00
21.97%
Operating Profit (PBDIT) excl Other Income
3,720.00
2,969.00
751.00
25.29%
Other Income
23.00
352.00
-329.00
-93.47%
Operating Profit (PBDIT)
3,744.00
3,321.00
423.00
12.74%
Interest
252.00
3.00
249.00
8,300.00%
Profit before Depriciation and Tax
3,491.00
3,318.00
173.00
5.21%
Depreciation
794.00
402.00
392.00
97.51%
Profit Before Taxation & Exceptional Items
2,697.00
2,916.00
-219.00
-7.51%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,672.00
2,916.00
-244.00
-8.37%
Provision for Tax
761.00
725.00
36.00
4.97%
Profit After Tax
1,911.00
2,191.00
-280.00
-12.78%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,942.00
11,786.00
-7,844.00
-66.55%
Profit Available for appropriations
5,853.00
13,977.00
-8,124.00
-58.12%
Appropriations
5,853.00
13,977.00
-8,124.00
-58.12%
Equity Dividend (%)
640%
1500%
-860.00
Earnings Per Share
56.47
82.53
-26.06
-31.58%
Profit And Loss - Net Sales
Net Sales 11,516.09 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.35% vs 11.51% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,720.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 10.49% vs 18.49% in Mar 2024

Profit And Loss - Interest
Interest 252.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -28.64% vs 6.03% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 1,911.25 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.39% vs 33.02% in Mar 2024